Regeringen: Mer kunskap behövs om postcovid

Regeringen vill öka kunskapsläget kring postcovid, särskilt när det kommer till behandling av barn. Socialstyrelsen och SBU får därför nya uppdrag.

Bioarctic granted Japanese patent for Parkinson’s disease candidate

Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.

Efter tio år på posten – Smiles vd lämnar över stafettpinnen

Ebba Fåhraeus har efter tio år på posten meddelat att hon önskar lämna rollen som vd för Smile Venture Hub. Hennes efterträdare blir nuvarande vice vd Ulrika Ringdahl.

Precision medicine centre: “Extensive activity on several fronts”

Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...

“Life science is important on a personal level”

From the High Coast to the Government Offices. Jeanette Edblad is a native of Ångermanland, and since September last year, she has been Head and Coordinator of ...

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

Medical Applications

Video about metrology solutions for medical components

QPS Netherlands B.V

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

TFS hämtar vd internt

Kontraktsforskningsbolaget TFS Health Science har utsett Markus Granlund till vd.

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

RegSmart Life Science AB

Från apotekare till poddare – Magnus Lejelöv har rösten som verktyg

Magnus Lejelöv har över 20 års erfarenhet från läkemedelssektorn och har intervjuat nära två hundra vårdprofiler i sina poddar. I maj står han på scenen i Lund ...

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

AI speeds up measurement process

How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

Valves with piezo technology

Efficient control and regulation of gases in medical technology

Implantatföretags grundare lämnar vd-posten

Medtechbolaget Integrums grundare Rickard Brånemark lämnar vd-posten och får i stället en rådgivande roll i bolaget. Ny tillförordnad vd är styrelseledamoten Scott Flora.

Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”

What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...

Explore the latest trends and innovations in quality assurance and manufacturing

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Moderna utvecklar mRNA-vaccin mot vinterkräksjukan

Ett synnerligen efterlängtat vaccin är i sen klinisk utvärdering, och kan vara moget för godkännande inom ett par år. Målet är noroviruset, som orsakar vinterkräksjukan.